Ajinomoto Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Tokyo Japan (1917)
Status: Left NME R&D (2023)

Organization Overview

First Clinical Trial
1999
NCT00002098
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Ajinomoto Co., Inc. | Ajinomoto Foods Europe SAS | Ajinomoto USA, INC. | AJI Pharma USA